RSS Amplifier

Podcast

Ask a Patient® Health News: Drugs & Treatments

Official newsletter of Ask a Patient® website. Find out about new drugs, safety alerts, promising research, medication and supplements tips. Sent every other week.

news.askapatient.comRSS feed ↗20 episodes

Written by

Latest episodes

New Drugs for Advanced Melanoma, ADHD, Narcolepsy, Pain, Prostate Cancer; Telehealth Lawsuit; Cell-Based Therapies; Tips for Bone Health

Roundup of recent drug approvals including the first OTC combination of naproxen and Tylenol; Pluvicto expansion for less severe forms of prostate cancer, virus-based treatment for advanced melanoma, new narcolepsy treatment, new ADHD stimulant that is first in its class, tips for bone health, what to expect when getting cell-based treatments. Also, a look at the FTC complaint against Hims and…

August 2026: Huge Recall of 162,000 Vials of Compounded Semaglutide by Apollo Care Due to Contamination With Nylon and Silk Protein Particles; Trokendi XR, Azelaic Gel, Dabigatran, Divalproex Recalls

A roundup of nine FDA drug recalls August 2026. Includes a large recall of semaglutide from Apollo compounding pharmacy because of particulate in the vials, Trokendi seizure/migraine med, overactive bladder med, and more.

July 2026: Huge Cetirizine, Amlodipine, Nystatin, Eye Drops Recalls; Pediatric Approvals; Eye Drops Tips; New Cholesterol Treatment; Blood Test News

A roundup of recent drug safety news, including Cetirizine (Zyrtec generic) Recall Due to Cross-Contamination with Zantac stomach acid medication. Eye drops tips, new drug approvals for kids, the blood test for Alzheimer's and more

Strattera (Atomoxetine) Revised Label, More Clarity, But is a Warning for Adults Still Missing?

Lilly updated the drug label for its non-stimulant ADHD (Attention-Deficit Hyperactivity Disorder) drug Strattera (Atomoxetine hydrochloride). Here's an idea about what was changed and what might have been left out of the revisions. The changes clarify boxed warnings, age indications, and to make other formatting changes to the label.

Ketamine Website Take-Downs; 2.5 Million Steroid Eye Drops Recalled; Stomach Bug Outbreak Update; Xeljanz and Rinvoq New Warnings; Understanding Kids' Rashes; More

FDA Warns Websites Selling Illegal Ketamine

Recalls for Chlorthalidone, Corlanor, Multiple Brands of Antifungals and Ointments; Oseltamivir (Tamiflu) Harms; Farxiga Generics; Medication Tips, More

Huge Amgen Recall of Corlanor and Sensipar; Drugs Discontinued; Tamiflu Harm in Hospitals; Xofluza Generic; Generics and New Warnings for Farxiga

Nationwide recall of Gas-X, Amlodipine, Epinephrine, Liraglutide; Safer Sunscreen Approved; How Dangerous Ingredients Get Into Food; New Warning for Migraine Meds; Choosing Hearing Aids and More

Popular Anti-Gas Drug Gas-X Potentially Contaminated with Coolant Recalled, plus How Dangerous Ingredients Get Into Food; New Warning for Migraine Meds; Choosing Hearing Aids and More

May 2026 Part 2: 100+ Cases of Supplement-Linked Salmonella in 36 States; Ramipril Warning; Tums, Erythromycin, Nicotine Patch Recall; Insulin Inhaler for Kids; Psychotherapy Caution

Important recent drug recalls and approvals: Outbreak of Supplement-Linked Salmonella Tops 100; Tums, Erythromycin, Nicotine Patch Recall; New warnings for Ramipril and Auvelity; New Insulin Inhaler for Kids; GLP-1 for Seniors; Mental Health Apps Caution, more

May 2026 Drug Safety: Recalls for Contaminated Skin Cream, Oasis, FreshKote Eye Drops; Approvals for MS, Myasthenia gravis; Parkinson’s Test Warning; Sham Clinical Trials; Chest Pain Consult Tips

Read recent news about recalls, new approvals for MS and Myasthenia Gravis, diagnosing Parkinson's; How some clinical trials only aim to increase drug sales, Initiative to reduce psychiatric drug use, problems with medical AI , what your doctor really needs to know to help diagnose your chest pain.

Nationwide Recall of Alcon, iVizia, Optane Eye Gel Drops; Furosemide, Pantoprazole, Prescription-Strength Fish Oil; New and Experimental Drug Approvals; Aspirin and Cancer Study

Important new medication recalls, including four eye drop brands, a Lasix generic and PPI. New treatments approvals and medication research about aspirin and cancer.

April 2026 Part 2: Recalls for Clonidine and Xanax XR; Health fraud scams; New warnings for Proscar, Eylea; Foundayo safety; Medication shortages; Lung cancer surgery, more

A roundup of recent safety news, recalls, and research.

April 2026: Nationwide Recall of 3.1 Million Eye Drops; Levothyroxine Recall; Clindomycin, Alli Warnings; New Cholesterol Screening Guidelines; Thyroid Medications Regulation

KC Pharma Recalls 3 Million Bottles of Store Brand Eye Drops , recalls of levothyroxine, new warnings for orlistat and clindamycin; thyroid medication news; new cholesterol guidlines.

Huge Recall of Children’s Ibuprofen, Apotex Eye Drops, Dangerous Dietary Supplements; Warnings for Levodopa, Xeljanz, Migraine Drugs, Sivextro, Children’s Xyzal; Antibiotics Research, Cancer Research

Summaries of recent FDA recall and drug warnings updates. This edition also features studies on antibiotic research and possible association between metformin and cancer prevention.

March 2026 Safety Update: Recalls for Metoprolol, Amantadine, Temozolomide, iKids Growth; Warnings for Paxlovid, Entyvio, Vabomere, Arthritis Pain Supplement

Metoprolol Succinate Extended-Release Recall by Teva

March 2026: Approvals for Promising Blood Cancer Treatment; Pediatric PKU Drug; Sinus Infections and Antibiotics; Health AI Tool Concerns; GLP-1 Pills Compared; Medication and Supplement Tips

Features notable drug approvals, research on health AI tools, comparing GLP-1 pills, and medication tips

Estradiol and Testosterone Recalls; Metoclopramide Warnings; Approvals for Pancreatic and Ovarian Cancer; Landmark PBM Reform; Pharma TV Commercials Flagged; Psychiatric Drugs and More

Recall of Estradiol and Testosterone Pellets from U.S. News at FDA on drug warnings for pharma ads, single trial requirement for drug applications, PBM reform, new cancer drug approvals, more.

February 2026 Safety Update: Trazodone Recall; Urgent Recall for CGM Sensors; Non-Statin Pill Lowers LDL; Eye Drops for Presbyopia; Ozempic Tablet; Osteoporosis Drugs; SRI Safety Concerns, More

Granules Recalls 50mg strength Trazodone

Pet Medication News: Recent Drug Approvals for Idiopathic Epilepsy and Lymphoma in Dogs; Minoxidil Warning; Largest-Ever Clinical Trial of Dogs Investigates Lifespan-Extending Treatment

Highlights of new drug approvals for dogs; research on a medication to increase a dog's lifespan, more.

January 2026: New or Expanded Approvals for: GLP-1 Weight Loss, Birth Control Implant, Lung Disease, Menkes, Gaucher; Omeprazole Research and Case Studies; Rx-OTC Switches; Medication Tips

GLP-1 New Products: Wegovy (semaglutide) Tablets and Multi-Dose Vials of Mounjaro and Zepbound (tirzepatide)

January 2026: Recalls for Oxycodone, Wegovy, Rosuvastatin, Clearlife Nasal Spray; Blood Thinner Bleeding Antidote Withdrawn; Depo Provera, Addyi, and Hair Loss Drug News, More

New Safety Warnings for Opioid Medications; recalls for Oycodone and More; New Hair Loss Drug being studied, Drug Label Safety updates.